BusinessWeek takes a tour of the mainstream medical research business – big pharma and the new biotech giants – to see how they are starting to pour money into regenerative medicine. Much of the focus today is on repairing damage to the “engines of life,” the heart and brain, but an amazing variety of privately funded work is taking place. There would be much more money, research, and progress if not for political threats to stem cell research, however. All advocates for regenerative medicine and freedom of research should take a look at what the privately funded marketplace is doing here – the self-interest and altruism do make good partners.
View the Article Under Discussion: http://www.businessweek.com/magazine/content/04_21/b3884001_mz001.htm
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/
